Team and Background

World Health Partners Management Consulting is a Swiss-based global network company with partner- collaborators and companies in over 20 countries (Brasil, USA, Canada, UK, France, Benelux, Italy, Spain, Germany, Mexico, Poland, Australia, Singapore, Turkey, UAE, Israel) stemming from collaborations over the last 35 years through Ciba-Geigy, Novartis, Wyeth, Pfizer, Vifor Pharma and the Trade Associations Interpharma, PhRMA and EFPIA). The network has broad market access experience but in particular in the areas of chronic diseases (Immune suppression, RA, CKD, GI, oncology, CHF,IDA) blood loss and diseases, vaccines and neuroscience.

The members of the network have efficient access to local healthcare deciders and policy makers and have all absolved Harvard Business School, Law and School of Public Health negotiation training backgrounds and local access experience.
WHP Management Consulting benefits of an academic network with Stockholm School of Economics (SSE), London School of Economics (LSE), Ecole Superieure de Science Economiques et Comerciales (ESSEC), Harvard University schools.


Members of the Board

Jorge Wernli (Founder), Vice President Pricing & Government Affairs Vifor Pharma
Dr. M. Halperin Wernli (Founder), Vice President, Deputy Head Global Clinical Development, Actelion
Dr. Peter Lauper (Founder), Ex Worldwide Vice President Johnson & Johnson, Senior Advisor

Academia Alliance Network

Prof. Lorenzo Mantovani, Universita Bocconi, Milano, Napoli
Prof. Bengt Joensson, Stockholm School of Economics (SSE)
Prof. Gerard de Pouvourville, Ecole Sep de Science Economicques et Commerciales (ESSEC)
Prof. David Nadal, Kinderspital Zuerich, Switzerland

Strategic Alliances

Jorge Felix, Managing Partner, EXIGO, Lisboa, Portugal
Justin Stindt Consulting, JSC, Paris, France, Germany Academia
Dr. Panos Kanavos, Inl Health Policy Development, Social Policies, LSE
Claudia Bettinaglio, Graphic Designer,, Basel, Switzerland

Consulting /Advisory Network/Foundations Network

Mike O’Neil, President Monere Consulting, Philadelphia, USA
Mark Gordon, Vantage Partners, Boston, USA
Takis Zervakakis, Chief Executive Officer ILS Consulting, Innovation in Life Sciences
Dr. Timm Volmer, MPH, Harvard School of Public Health, SmartStep Consulting GmbH Healthcare Strategy & Market Access Consulting
Dr. Francesco Conti, President Fondazione Charta, Milano, Italy
Patrick Johnson PhD, Consulting M&S Statistician, JPharma Solutions GmbH, Switzerland
Eva Kalias, MS Biochemistry University of Zuerich, MBA IMD Communication, VioConsult, Zuerich
Dr. Lamine Mahi, Axelys Santé, Paris, France
Jenny Dietschweiler, Personal Trainer, Chilli Fitness, 8700 Männedorf, Switzerland
Dr. Carine Abt, Health4U, Switzerland
Daniel T. Kessler, Governance, Risk Management & Compliance Lawyer, Givon Advisors Ltd/ITR Compliance Group
Joe Henein, NB Pharma, Dubai, UAE
David Danko, Ideas & Solutions Consulting and Research Leader Corvinius University Budapest, Hungary
Dr. Harlald Rinde, BioBridge Strategies, Halteres Associates, LLC, California, San Diego, Binningen
Klaas Duijn, Health Care Consultancy, The Netherlands, Market access ,strategy & negotiations, coaching
Christian Huyghe, Healthcare Sector Entrepreneur, Brussels, Belgium

Pharmaceuticals Entrepreneurs

Dr. David Ebsworth, non- executive Chairman Verona Pharmaceuticals
Ulf Wiinberg, Pharmaceuticals Entrepreneur